Original Versus Generic Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Comparison of Efficacy and Adverse Events

OBJECTIVE: Lenalidomide is an effective immunomodulatory derivative drug used in the treatment of multiple myeloma (MM). It is available in original and generic forms in Turkey, but there is no clinical study that has compared the effectiveness and adverse events (AEs) of the generic and original fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolaman, Ali Zahit, Turgutkaya, Atakan, Sahip, Birsen, Selim, Cem, Eroğlu Küçükdiler, Hilal, Ertop, Şehmus, Sargın, Gökhan, Yavaşoğlu, İrfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927438/
https://www.ncbi.nlm.nih.gov/pubmed/33342205
http://dx.doi.org/10.4274/tjh.galenos.2020.2020.0169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927438/
https://www.ncbi.nlm.nih.gov/pubmed/33342205
http://dx.doi.org/10.4274/tjh.galenos.2020.2020.0169

Ejemplares similares